COX-2 inhibitors and cardiovascular risk: The data are inconclusive, and these drugs are needed

Article Type
Article
Changed
Fri, 02/01/2019 - 09:09
Display Headline
COX-2 inhibitors and cardiovascular risk: The data are inconclusive, and these drugs are needed
Author(s)
John Lipani, MD
Article PDF
content_68_961.pdf
Author and Disclosure Information

John Lipani, MD
Clinical rheumatologist and researcher; president, Histatek Inc., Fountain Hills, AZ

Address: John Lipani, MD, 16107 East Emerald Drive, #102, Fountain Hills, AZ 85268

Issue
Cleveland Clinic Journal of Medicine - 68(11)
Publications
Cleveland Clinic Journal of Medicine
Topics
Cardiology
Drug Therapy
Rheumatology
Vascular
Page Number
961-962
Sections
Commentary
Author(s)
John Lipani, MD
Author(s)
John Lipani, MD
Author and Disclosure Information

John Lipani, MD
Clinical rheumatologist and researcher; president, Histatek Inc., Fountain Hills, AZ

Address: John Lipani, MD, 16107 East Emerald Drive, #102, Fountain Hills, AZ 85268

Author and Disclosure Information

John Lipani, MD
Clinical rheumatologist and researcher; president, Histatek Inc., Fountain Hills, AZ

Address: John Lipani, MD, 16107 East Emerald Drive, #102, Fountain Hills, AZ 85268

Article PDF
content_68_961.pdf
Article PDF
content_68_961.pdf
Related Articles
COX-2 inhibitors: Balancing the hope, the hype, and the concern
COX-2 inhibitors and cardiovascular risk: Point and counterpoint
COX-2 inhibitors and cardiovascular risk: We defend our data and suggest caution
Issue
Cleveland Clinic Journal of Medicine - 68(11)
Issue
Cleveland Clinic Journal of Medicine - 68(11)
Page Number
961-962
Page Number
961-962
Publications
Cleveland Clinic Journal of Medicine
Publications
Cleveland Clinic Journal of Medicine
Topics
Cardiology
Drug Therapy
Rheumatology
Vascular
Article Type
Article
Display Headline
COX-2 inhibitors and cardiovascular risk: The data are inconclusive, and these drugs are needed
Display Headline
COX-2 inhibitors and cardiovascular risk: The data are inconclusive, and these drugs are needed
Sections
Commentary
PURLs Copyright

Disallow All Ads
Alternative CME
Use ProPublica
Article PDF Media
Subscribe to John Lipani, MD